Cover Image

Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model

Chloroquine (CQ) and hydroxychloroquine (HCQ) have been challenged in treating COVID-19 patients and still under debate due to the uncertainty regarding the effectiveness and safety, and there is still lack of the systematic study on the toxicity of these two drugs. To further uncover the toxicity p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jianling Yang (Author), Zhengyang Guo (Author), Xu Liu (Author), Qi Liu (Author), Meng Wu (Author), Xueting Yao (Author), Yang Liu (Author), Cheng Cui (Author), Haiyan Li (Author), Chunli Song (Author), Dongyang Liu (Author), Lixiang Xue (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model
by: Cheng Cui, et al.
Published: (2020)

Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients
by: Miao Zhang, et al.
Published: (2021)

Time-Dependent Distribution of Hydroxychloroquine in Cynomolgus Macaques Using Population Pharmacokinetic Modeling Method
by: Qi Liu, et al.
Published: (2021)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
by: Babayeva M, et al.
Published: (2020)

Chloroquine and hydroxychloroquine in the context of COVID-19
by: Ashutosh M Shukla, et al.
Published: (2020)

Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis
by: Liu D, et al.
Published: (2018)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
by: Javad Mahmoudi, et al.
Published: (2021)

Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
by: Yan Chen, et al.
Published: (2020)

Chloroquine and Hydroxychloroquine: Potentially Inappropriate Medications for Older Adults?
by: Milton Gorzoni
Published: (2024)

Prophylactic Effect of Chloroquine and Hydroxychloroquine on COVID-19 Treatment
by: Amin Ataie, et al.
Published: (2022)

Rational use of chloroquine and hydroxychloroquine in times of COVID-19
by: Rosa Camila Lucchetta, et al.
Published: (2020)

Administration of chloroquine and hydroxychloroquine through feeding tubes: that was then and this is now
by: Mariana Martins Gonzaga Nascimento, et al.
Published: (2022)

Prediction of pyrotinib exposure based on physiologically-based pharmacokinetic model and endogenous biomarker
by: Miao Zhang, et al.
Published: (2022)

Dose Prediction and Pharmacokinetic Simulation of XZP-5610, a Small Molecule for NASH Therapy, Using Allometric Scaling and Physiologically Based Pharmacokinetic Models
by: Lei Zhang, et al.
Published: (2024)

Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis
by: Lu Ren, et al.
Published: (2020)

The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
by: Elangovan Manivannan, et al.
Published: (2021)

Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19
by: Jarir At Thobari
Published: (2021)

Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?
by: Pathiyil Ravi Shankar, et al.
Published: (2021)

Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
by: Partha Sarathi Biswas, et al.
Published: (2020)

Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19
by: Christina B. Klouda, et al.
Published: (2020)

Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues
by: Ashutosh M Shukla, et al.
Published: (2019)

Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
by: Kavous Shahsavarinia, et al.
Published: (2021)

Chloroquine and hydroxychloroquine repositioning in times of COVID-19 pandemics, all that glitters is not gold
by: Francisco José Roma Paumgartten, et al.

Ontology-Based Classification and Analysis of Adverse Events Associated With the Usage of Chloroquine and Hydroxychloroquine
by: Jamie Ngai, et al.
Published: (2022)

Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety
by: Michael Takla, et al.
Published: (2020)

A systematic review on the therapeutic relevance of hydroxychloroquine/chloroquine in the management of COVID-19
by: Gerard Mccabe, et al.
Published: (2021)

Potential drug-drug interaction of olverembatinib (HQP1351) using physiologically based pharmacokinetic models
by: Zhiheng Yu, et al.
Published: (2022)

A Critical Review of Chloroquine and Hydroxychloroquine as Potential Adjuvant Agents for Treating People with Cancer
by: Amal Kamal Abdel-Aziz, et al.
Published: (2022)

Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review
by: Pattarawadee Prayuenyong, et al.
Published: (2020)

Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment
by: Niteen A. Vaidya, et al.
Published: (2020)

Administration of chloroquine or hydroxychloroquine through feeding tubes: new challenges in times of coronavirus pandemic
by: Mariana Martins Gonzaga do Nascimento, et al.
Published: (2020)

Chloroquine and Hydroxychloroquine, as Proteasome Inhibitors, Upregulate the Expression and Activity of Organic Anion Transporter 3
by: Zhengxuan Liang, et al.
Published: (2023)

PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients
by: Xu Liu, et al.
Published: (2023)

Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
by: Saghir SAM, et al.
Published: (2021)

Local Anesthetic Like Inhibition of the Cardiac Na+ Channel Nav1.5 by Chloroquine and Hydroxychloroquine
by: Hage A, et al.
Published: (2022)

Is it worth the wait? Should Chloroquine or Hydroxychloroquine be allowed for immediate use in CoViD-19?
by: Syed Shahzad Hasan, et al.
Published: (2020)

Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study
by: Hao Liang, et al.
Published: (2024)

Predicting Hydroxychloroquine Clearance in Healthy and Diseased Populations Using a Physiologically Based Pharmacokinetic Approach
by: Faleh Alqahtani, et al.
Published: (2023)

Chloroquine and Hydroxychloroquine Use During Pregnancy and the Risk of Adverse Pregnancy Outcomes Using Real-World Evidence
by: Anick Bérard, et al.
Published: (2021)

The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review
by: Subham Das, et al.
Published: (2021)